MENU
LUCD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Lucid Diagnostics (LUCD) Ownership - Who owns Lucid Diagnostics?

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma... Show more

Profile

Industry
N/A
Address
360 Madison Avenue
Phone
+1 917 813-1828
Employees
82
Web
https://www.luciddx.com

Details

Group
Domestic Stock Funds
Category
Health Services
Capitalization
189.47M
P/E Ratio
N/A
Total Cash
27.88M
Projected Growth
N/A
Total Debt
26.8M
Revenue
5.13M
Risk (Beta)
-0.02
Dividend Yield
N/A
Total Cash/Share
0.15
Total Debt/Equity
N/A
Revenue/Share
0.04 USD as % of share price
View a ticker or compare two or three
LUCD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Details
Industry
N/A
Address
360 Madison Avenue
Phone
+1 917 813-1828
Employees
82
Web
https://www.luciddx.com